Correlation Between Dupont De and Ascendis Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Dupont De and Ascendis Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dupont De and Ascendis Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dupont De Nemours and Ascendis Pharma AS, you can compare the effects of market volatilities on Dupont De and Ascendis Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dupont De with a short position of Ascendis Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dupont De and Ascendis Pharma.

Diversification Opportunities for Dupont De and Ascendis Pharma

0.5
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Dupont and Ascendis is 0.5. Overlapping area represents the amount of risk that can be diversified away by holding Dupont De Nemours and Ascendis Pharma AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ascendis Pharma AS and Dupont De is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dupont De Nemours are associated (or correlated) with Ascendis Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ascendis Pharma AS has no effect on the direction of Dupont De i.e., Dupont De and Ascendis Pharma go up and down completely randomly.

Pair Corralation between Dupont De and Ascendis Pharma

Allowing for the 90-day total investment horizon Dupont De Nemours is expected to under-perform the Ascendis Pharma. But the stock apears to be less risky and, when comparing its historical volatility, Dupont De Nemours is 1.3 times less risky than Ascendis Pharma. The stock trades about -0.03 of its potential returns per unit of risk. The Ascendis Pharma AS is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  12,769  in Ascendis Pharma AS on August 24, 2024 and sell it today you would earn a total of  1.00  from holding Ascendis Pharma AS or generate 0.01% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Dupont De Nemours  vs.  Ascendis Pharma AS

 Performance 
       Timeline  
Dupont De Nemours 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Dupont De Nemours are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound fundamental indicators, Dupont De is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders.
Ascendis Pharma AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ascendis Pharma AS has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Ascendis Pharma is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Dupont De and Ascendis Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Dupont De and Ascendis Pharma

The main advantage of trading using opposite Dupont De and Ascendis Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dupont De position performs unexpectedly, Ascendis Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ascendis Pharma will offset losses from the drop in Ascendis Pharma's long position.
The idea behind Dupont De Nemours and Ascendis Pharma AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Complementary Tools

Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum